Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 5 (2008), Issue 2 (February)

1. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
   Gynecol Oncol, 108(2): 377-84. [Abstract] [Full-text]
2. Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
   Gynecol Oncol, 108(2): 449-51. [Abstract] [Full-text]
3. Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer.
   Gynecol Oncol, 108(2): 317-25. [Abstract] [Full-text]
4. Robotic radical hysterectomy with pelvic lymphadenectomy for cervical carcinoma: a pilot study.
   Gynecol Oncol, 108(2): 312-6. [Abstract] [Full-text]
5. Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
   Gynecol Oncol, 108(2): 326-31. [Abstract] [Full-text]
6. The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines.
   Cancer Invest, 26(2): 136-44. [Abstract] [Full-text]
7. Natural history and clearance of HPV after treatment of precancerous cervical lesions.
   Histopathology, 52(3): 381-6. [Abstract] [Full-text]
8. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
   Cancer Gene Ther, 15(3): 140-53. [Abstract] [Full-text]
9. New viral vaccines for dermatologic disease.
   J Am Acad Dermatol, 58(3): 361-70. [Abstract] [Full-text]
10. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
    Mol Cancer, 7: 3. [Abstract] [Full-text]
11. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Cancer, 112(3): 626-35. [Abstract] [Full-text]
12. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy.
    Gynecol Oncol, 108(3): 472-7. [Abstract] [Full-text]
13. HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue.
    Gynecol Oncol, 108(3): 555-60. [Abstract] [Full-text]
14. Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.
    Gynecol Oncol, 108(3): 598-602. [Abstract] [Full-text]
15. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
    Gynecol Oncol, 108(3): 466-71. [Abstract] [Full-text]
16. Gene expression in early stage cervical cancer.
    Gynecol Oncol, 108(3): 520-6. [Abstract] [Full-text]
17. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
    Gynecol Oncol, 108(3): 549-54. [Abstract] [Full-text]
18. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Gynecol Oncol, 108(3): 533-42. [Abstract] [Full-text]
19. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Gynecol Oncol, 108(3): 591-7. [Abstract] [Full-text]
20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Gynecol Oncol, 108(3): 527-32. [Abstract] [Full-text]
21. Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV).
    Gynecol Oncol, 108(3): 543-8. [Abstract] [Full-text]
22. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
    Int J Cancer, 122(8): 1901-4. [Abstract] [Full-text]
23. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    Int J Cancer, 122(8): 1854-8. [Abstract] [Full-text]
24. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
    Oncogene, 27(10): 1376-86. [Abstract] [Full-text]
25. Classification of radical hysterectomy.
    Lancet Oncol, 9(3): 297-303. [Abstract] [Full-text]
26. Do women comply with recommendations for Papanicolaou smears following colposcopy? A retrospective study.
    J Midwifery Womens Health, 53(2): 138-42. [Abstract] [Full-text]

© 2004-2008 Cervical Cancer Research Today. All Rights Reserved.